Litigation Details for VALEANT PHARMACEUTICALS NORTH AMERICA LLC v. CIPLA LTD. (D.N.J. 2019)
✉ Email this page to a colleague
VALEANT PHARMACEUTICALS NORTH AMERICA LLC v. CIPLA LTD. (D.N.J. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-01-23 |
| Court | District Court, D. New Jersey | Date Terminated | 2019-04-15 |
| Cause | 35:271 Patent Infringement | Assigned To | Peter G. Sheridan |
| Jury Demand | None | Referred To | Lois H. Goodman |
| Patents | 10,105,444; 7,214,506; 8,039,494; 8,486,978; 9,302,009; 9,566,272; 9,662,394; 9,861,698; 9,877,955 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in VALEANT PHARMACEUTICALS NORTH AMERICA LLC v. CIPLA LTD.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for VALEANT PHARMACEUTICALS NORTH AMERICA LLC v. CIPLA LTD. (D.N.J. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2019-01-22 | 1 | United States Patent No. 10,105,444 (“the ’444 patent”) arising under the United States patent laws, Title…of United States Patent Nos. 7,214,506 (“the ’506 patent”), 8,039,494 (“the ’494 patent”), 8,486,978 (“…(“the ’978 patent”), 9,302,009 (“the ’009 patent”), 9,566,272 (“the ’272 patent”), 9,662,394 (“the ’394…394 patent”), 9,861,698 (“the ’698 patent”), and 9,877,955 (“the ’955 patent”). That action is currently… THE PATENT IN SUIT 18. The United States Patent and Trademark Office ( | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
